A US Navy veteran who one day began having severe chest and back pain was diagnosed with stage 2 pancreatic cancer—one of the deadliest. According to doctors, the symptoms she had were completely ...
The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...
Intech Investment Management LLC purchased a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) in the third quarter, HoldingsChannel.com reports. The institutional ...
Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. | Profound Medical CEO Arun Menawat discusses TULSA-PRO, an innovative technology for treating ...
Stable disease (SD) at four months post-initiation of dosing was seen in 10 of 21 (48%) evaluable monotherapy patients, and importantly included one patient dosed at the MTD who had a partial response ...
Research and development (R&D) activities are anticipated to drive growth in the adenosine antagonists market by identifying novel therapeutic applications, such as in neurodegenerative diseases, ...